6.9
Agonistes adrénergiques : Classification thérapeutique
Les agonistes adrénergiques peuvent être classés en fonction de leurs utilisations thérapeutiques et de leurs mécanismes d'action. Ils servent à diver…
Les agonistes adrénergiques sont classés en fonction de leur mécanisme d’action. De plus, les sympathomimétiques peuvent également être classés en fonction de leurs actions thérapeutiques.
Les agents presseurs, ou vasopresseurs, sont utilisés pour élever l’hypotension artérielle. Il s’agit notamment de catécholamines endogènes, telles que la noradrénaline, et d’agents synthétiques comme la phényléphrine.
Ils servent également de stimulants cardiaques en augmentant la fréquence cardiaque, la force de contractilité et la vitesse de conduction.
Les bronchodilatateurs comprennent β 2-agonistes tels que le salbutamol et la terbutaline. Ils détendent les muscles pulmonaires et élargissent les voies respiratoires, ce qui facilite la respiration.
α-agonistes comme l’oxymétazoline et la phényléphrine agissent comme des décongestionnants. Ils aident à soulager la congestion nasale et à dégager les nez bouchés.
Les sympathomimétiques non catécholamines, tels que l’amphétamine, agissent comme des stimulants du SNC. Ils induisent de l’agitation, de l’euphorie et de l’insomnie par la libération de DA et de sérotonine.
β 2-agonistes comme la ritodrine sont utilisés pour détendre l’utérus et retarder le travail prématuré.
View the full transcript and gain access to JoVE Core videos
Q1: What are pressor agents and how do they work?
Pressor agents, or vasopressors, elevate low blood pressure and function as cardiac stimulants by increasing heart rate, force of contractility, and conduction velocity. Examples include endogenous catecholamines like noradrenaline and synthetic agents such as phenylephrine, making them essential for managing hypotensive conditions and supporting cardiovascular function.
Q2: How do beta-2 agonists relieve respiratory symptoms?
Beta-2 agonists like salbutamol and terbutaline relax bronchial muscles and widen airways, making breathing easier for patients with obstructive pulmonary disorders and asthma. These drugs reduce airway constriction and improve airflow by directly relaxing lung smooth muscle tissue through receptor activation.
Q3: What is the mechanism of action for decongestants?
Alpha-agonists like oxymetazoline and phenylephrine act as decongestants by constricting blood vessels in nasal tissues, reducing swelling and congestion. This vasoconstriction of the nasal mucosa helps relieve stuffy or blocked noses and sinuses by decreasing tissue edema and improving airflow through nasal passages.
Q4: How do indirect-acting CNS stimulants produce their effects?
Noncatecholamine sympathomimetics like amphetamine act as indirect-acting CNS stimulants by triggering the release of dopamine and serotonin rather than binding directly to receptors. These neurotransmitters induce restlessness, euphoria, and insomnia, distinguishing indirect-acting agents from direct-acting agents that bind adrenergic receptors.
Q5: What role do beta-2 agonists play in obstetrics?
Beta-2 agonists like ritodrine relax uterine smooth muscle and delay premature labor by reducing uterine contractions. By providing additional time for fetal development, these agents allow for interventions to improve maternal and fetal outcomes in at-risk pregnancies and support better neonatal health.
Q6: How are adrenergic agonists classified therapeutically?
Adrenergic agonists are classified based on their therapeutic actions and mechanisms of action. Major categories include vasopressors for blood pressure support, bronchodilators for airway relaxation, decongestants for nasal relief, CNS stimulants for neural effects, uterine relaxants for labor management, and beta-3 agonists for treating urinary incontinence.
Q7: What distinguishes catecholamine from noncatecholamine sympathomimetics?
Catecholamines like noradrenaline and dopamine are endogenous compounds that bind directly to adrenergic receptors, while noncatecholamine sympathomimetics like amphetamine lack the catechol moiety and work indirectly. Indirect agents trigger drugs affecting neurotransmitter release or uptake rather than direct receptor binding, producing different pharmacological profiles.